On November 7, 2012, EnteroMedics Inc. (the "Company") issued a press release announcing that hypertension data from a subgroup analysis of the EMPOWER trial was presented at the American Heart Association's 2012 Scientific Sessions held November 3-7 in Los Angeles, California. Copies of this press release and presentation are furnished herewith as Exhibits 99.1 and 99.2 to this Current Report on Form 8-K.

The information in this Current Report on Form 8-K and in the accompanying exhibit shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Current Report on Form 8-K and in the accompanying exhibits shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

(d) Exhibits

          Exhibit No.   Description

             99.1       Press release dated November 7, 2012.

             99.2       AHA 2012 Presentation made on November 7, 2012.